FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220985215> ?p ?o ?g. }

• W4220985215 abstract "The high global burden of cryptococcosis has made development of a protective vaccine a public health priority. We previously demonstrated that a vaccine composed of recombinant Cryptococcus neoformans chitin deacetylase 2 (Cda2) delivered in glucan particles (GPs) protects BALB/c and C57BL/6 mice from an otherwise lethal challenge with a highly virulent C. neoformans strain. An immunoinformatic analysis of Cda2 revealed a peptide sequence predicted to have strong binding to the major histocompatibility complex class II (MHC II) H2-IAd allele found in BALB/c mice. BALB/c mice vaccinated with GPs containing a 32-amino-acid peptide (Cda2-Pep1) that included this strong binding region were protected from cryptococcosis. Protection was lost with GP-based vaccines containing versions of recombinant Cda2 protein and Cda2-Pep1 with mutations predicted to greatly diminish MHC II binding. Cda2 has homology to the three other C. neoformans chitin deacetylases, Cda1, Cda3, and Fpd1, in the high-MHC II-binding region. GPs loaded with homologous peptides of Cda1, Cda3, and Fpd1 protected BALB/c mice from experimental cryptococcosis, albeit not as robustly as the Cda2-Pep1 vaccine. Finally, seven other peptides were synthesized based on regions in Cda2 predicted to contain promising CD4+ T cell epitopes in BALB/c or C57BL/6 mice. While five peptide vaccines significantly protected BALB/c mice, only one protected C57BL/6 mice. Thus, GP-based vaccines containing a single peptide can protect mice against cryptococcosis. However, given the diversity of human MHC II alleles, a peptide-based Cryptococcus vaccine for use in humans would be challenging and likely need to contain multiple peptide sequences. IMPORTANCE Cryptococcosis, due to infection by fungi of the Cryptococcus neoformans species complex, is responsible for substantial morbidity and mortality in immunocompromised persons, particularly those with AIDS. Cryptococcal vaccines are a public health priority yet are not available for human use. We previously demonstrated mice could be protected from experimental cryptococcosis with vaccines composed of recombinant cryptococcal proteins encased in hollow highly purified yeast cell walls (glucan particles). In this study, we examined one such protective protein, Cda2, and using bioinformatics, we identified a region predicted to stimulate strong T cell responses. A peptide containing this region formulated in glucan particle-based vaccines protected mice as well as the recombinant protein. Other peptide vaccines also protected, including peptides containing sequences from proteins homologous to Cda2. These preclinical mouse studies provide a proof of principle that peptides can be effective as vaccines to protect against cryptococcosis and that bioinformatic approaches can guide peptide selection." @default.
• W4220985215 created "2022-04-03" @default.
• W4220985215 creator A5021951350 @default.
• W4220985215 creator A5033204818 @default.
• W4220985215 creator A5033310887 @default.
• W4220985215 creator A5035268981 @default.
• W4220985215 creator A5054141043 @default.
• W4220985215 creator A5056742280 @default.
• W4220985215 creator A5057141142 @default.
• W4220985215 creator A5061159041 @default.
• W4220985215 creator A5081023775 @default.
• W4220985215 creator A5082676196 @default.
• W4220985215 date "2022-02-22" @default.
• W4220985215 modified "2023-09-30" @default.
• W4220985215 title "Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles" @default.
• W4220985215 cites W1501132183 @default.
• W4220985215 cites W1994282287 @default.
• W4220985215 cites W1999361720 @default.
• W4220985215 cites W2005361432 @default.
• W4220985215 cites W2017758723 @default.
• W4220985215 cites W2049860314 @default.
• W4220985215 cites W2062499819 @default.
• W4220985215 cites W2082580360 @default.
• W4220985215 cites W2084965322 @default.
• W4220985215 cites W2104281761 @default.
• W4220985215 cites W2107794472 @default.
• W4220985215 cites W2111314562 @default.
• W4220985215 cites W2112662171 @default.
• W4220985215 cites W2120277859 @default.
• W4220985215 cites W2126715684 @default.
• W4220985215 cites W2132217769 @default.
• W4220985215 cites W2136981189 @default.
• W4220985215 cites W2141210267 @default.
• W4220985215 cites W2152130909 @default.
• W4220985215 cites W2154503908 @default.
• W4220985215 cites W2160765050 @default.
• W4220985215 cites W2164390512 @default.
• W4220985215 cites W2168478752 @default.
• W4220985215 cites W2169908075 @default.
• W4220985215 cites W2170290365 @default.
• W4220985215 cites W2171953577 @default.
• W4220985215 cites W2192071399 @default.
• W4220985215 cites W2219979778 @default.
• W4220985215 cites W2323929490 @default.
• W4220985215 cites W2357298441 @default.
• W4220985215 cites W2472161222 @default.
• W4220985215 cites W2611697423 @default.
• W4220985215 cites W2766903030 @default.
• W4220985215 cites W2768821520 @default.
• W4220985215 cites W2799394015 @default.
• W4220985215 cites W2801765546 @default.
• W4220985215 cites W2901914345 @default.
• W4220985215 cites W2925396590 @default.
• W4220985215 cites W2967539922 @default.
• W4220985215 cites W2975098472 @default.
• W4220985215 cites W2985361774 @default.
• W4220985215 cites W2990051085 @default.
• W4220985215 cites W3003251053 @default.
• W4220985215 cites W3005109537 @default.
• W4220985215 cites W3007680806 @default.
• W4220985215 cites W3134624653 @default.
• W4220985215 cites W4231689503 @default.
• W4220985215 doi "https://doi.org/10.1128/mbio.03367-21" @default.
• W4220985215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35089095" @default.
• W4220985215 hasPublicationYear "2022" @default.
• W4220985215 type Work @default.
• W4220985215 citedByCount "13" @default.
• W4220985215 countsByYear W42209852152022 @default.
• W4220985215 countsByYear W42209852152023 @default.
• W4220985215 crossrefType "journal-article" @default.
• W4220985215 hasAuthorship W4220985215A5021951350 @default.
• W4220985215 hasAuthorship W4220985215A5033204818 @default.
• W4220985215 hasAuthorship W4220985215A5033310887 @default.
• W4220985215 hasAuthorship W4220985215A5035268981 @default.
• W4220985215 hasAuthorship W4220985215A5054141043 @default.
• W4220985215 hasAuthorship W4220985215A5056742280 @default.
• W4220985215 hasAuthorship W4220985215A5057141142 @default.
• W4220985215 hasAuthorship W4220985215A5061159041 @default.
• W4220985215 hasAuthorship W4220985215A5081023775 @default.
• W4220985215 hasAuthorship W4220985215A5082676196 @default.
• W4220985215 hasBestOaLocation W42209852153 @default.
• W4220985215 hasConcept C104317684 @default.
• W4220985215 hasConcept C147483822 @default.
• W4220985215 hasConcept C159047783 @default.
• W4220985215 hasConcept C195616568 @default.
• W4220985215 hasConcept C203014093 @default.
• W4220985215 hasConcept C207936829 @default.
• W4220985215 hasConcept C2776789287 @default.
• W4220985215 hasConcept C2777893358 @default.
• W4220985215 hasConcept C2779281246 @default.
• W4220985215 hasConcept C2779413141 @default.
• W4220985215 hasConcept C40767141 @default.
• W4220985215 hasConcept C55493867 @default.
• W4220985215 hasConcept C86803240 @default.
• W4220985215 hasConcept C89423630 @default.
• W4220985215 hasConceptScore W4220985215C104317684 @default.
• W4220985215 hasConceptScore W4220985215C147483822 @default.
• W4220985215 hasConceptScore W4220985215C159047783 @default.
• W4220985215 hasConceptScore W4220985215C195616568 @default.
• W4220985215 hasConceptScore W4220985215C203014093 @default.

• next